Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Moreover, if, as we believe, 2.0 has at least equal efficacy compared to 1.0 and WITHOUT the need for centrifuge, the value of announcing the results of the FIRST trial by formal publication as soon as possible is hardly useless. Are you not trying to build a long-term following? Marketing 101: promote what is worthy of promotion as early and consistently as possible. This will result in a chain of increasingly interested investors who follow your chain of progressive updates. The only rationale for not following this approach is if they want to keep the PPS DOWN—which is hardly in the shareholders’ interest.